11-7038750-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_176822.4(NLRP14):c.164G>A(p.Arg55Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.19 in 1,613,480 control chromosomes in the GnomAD database, including 31,931 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_176822.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLRP14 | NM_176822.4 | c.164G>A | p.Arg55Gln | missense_variant | 2/12 | ENST00000299481.5 | NP_789792.1 | |
NLRP14 | XM_011520044.2 | c.164G>A | p.Arg55Gln | missense_variant | 2/11 | XP_011518346.1 | ||
NLRP14 | XM_047426867.1 | c.164G>A | p.Arg55Gln | missense_variant | 2/11 | XP_047282823.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLRP14 | ENST00000299481.5 | c.164G>A | p.Arg55Gln | missense_variant | 2/12 | 5 | NM_176822.4 | ENSP00000299481 | P1 |
Frequencies
GnomAD3 genomes AF: 0.151 AC: 23020AN: 152088Hom.: 2153 Cov.: 32
GnomAD3 exomes AF: 0.148 AC: 37151AN: 250728Hom.: 3323 AF XY: 0.151 AC XY: 20457AN XY: 135588
GnomAD4 exome AF: 0.194 AC: 284024AN: 1461274Hom.: 29778 Cov.: 36 AF XY: 0.193 AC XY: 140056AN XY: 726924
GnomAD4 genome AF: 0.151 AC: 23026AN: 152206Hom.: 2153 Cov.: 32 AF XY: 0.145 AC XY: 10770AN XY: 74410
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 10, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
NLRP14-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at